Seerpharma.com.au :: Pharmaceutical Consulting & Training :: Validation, GMP & Compliance UK | Singapore | Korea

   

 

 

Chronic Obstructive Pulmonary Disease: Cause

Description: Chronic obstructive pulmonary disease is characterized by progressive airflow limitation that cannot be fully reversed, as well as abnormal inflammation due to chronic inhalation of particles or noxious gas. Symptoms rarely manifest in patients younger than age 40, though after onset, respiratory function declines precipitously over several years. This course will provide the basic information you need to understand the pathophysiology and epidemiology of COPD.

COURSE OUTLINE
INTRODUCTION
1. Course Information
2. Interface Tour
3. Course Overview

MECHANISM OF BREATHING
4. Objectives
5. Pulmonary Ventilation
6. Lung Volumes
7. Gas Dilution and Plethysmography
8. Progress Check

PATHOPHYSIOLOGY OF COPD
9. Objectives
10. Definition
11. Risk Factors
12. Pathophysiology
13. Consequences
14. Progress Check

EPIDEMIOLOGY
15. Objectives
16. Prevalence
17. Smoking and COPD
18. Mortality
19. Progress Check

CONCLUSION
20. Summary




COURSE OBJECTIVES
Students completing this course should be able to:
  • Describe respiration mechanisms
  • Explain respiratory air volume measures
  • Contrast emphysema, chronic bronchitis, and COPD
  • Identify COPD environmental and genetic risk factors
  • Explain how inflammation and direct airway damage can contribute to COPD pathogenesis
  • Describe COPD prevalence and its common comorbid diseases
  • State COPD mortality rates

 

   

SeerPharma has partnered with GeneEd to now distribute courses in Major Therapeutic Areas, Clinical Research, and Biotechnology & Genetics.

© SeerPharma Pty Ltd 2008 | Resources | Privacy Policy